文献速递瘢痕与激光烧伤

年龄对烧伤增生性瘢痕激光疗效的影响

Age as a Determinant: Investigating the Efficacy of Laser Treatment Outcomes for Burn Hypertrophic Scar Across Age Cohorts.
PubMed 文献 · J Burn Care Res · 2026-01-01

单中心回顾性队列研究纳入119例接受3次以上点阵剥脱性CO2激光治疗的烧伤增生性瘢痕患者,按k-means聚类分为年轻、中年和老年组。结果显示各年龄组POSAS指标均显著改善,但老年组观察者柔韧性量表仅1次治疗后即显著改善,而年轻和中年组需2次以上;中年组基线疼痛和瘙痒最高且改善最持续。

要点

  • 老年组POSAS观察者柔韧性仅1次激光即显著改善(P<.05),年轻和中年组需≥2次(P<.001)。
  • 中年组基线疼痛6.17/10和瘙痒6.64/10最高,高于年轻组和老年组(P<.05)。
  • 各年龄组激光后均有显著改善,但硬度计测量仅中年组显著变化(P<.05)。

核心结论

  • 年龄显著影响烧伤增生性瘢痕激光治疗结局,老年患者POSAS观察者量表改善更早更明显。
  • 各年龄组激光治疗后均有显著改善,但疼痛和瘙痒水平随治疗次数变化不同。

研究设计与样本

  • 单中心回顾性队列研究,纳入119例接受3次及以上点阵剥脱性CO2激光治疗的烧伤增生性瘢痕患者。
  • 采用k-means聚类将患者分为年轻、中年和老年组,平均年龄44.86岁(±16.4),女性49.58%。

主要发现

  • 老年组POSAS观察者柔韧性量表在1次治疗后显著改善(P<.05),年轻和中年组需2次以上(P<.001)。
  • 中年组基线疼痛和瘙痒平均分最高,分别为6.17/10和6.64/10,年轻组为4.26和4.97,老年组为4.26和4.74(P<.05)。
  • 所有组疼痛和瘙痒均显著下降,中年组改善最持续(P<.05)。
  • Vancouver瘢痕量表所有组均显著改善,硬度计测量仅中年组显著变化(P<.05)。
  • 患者以非洲裔美国人为主(38.7%),Fitzpatrick皮肤分型最常见的为V型(32.8%)和II型(20.2%)。

临床怎么用

  • 老年烧伤增生性瘢痕患者可考虑更早评估激光疗效,因其POSAS观察者柔韧性改善出现更快。
  • 中年患者基线疼痛和瘙痒更重,激光治疗中应加强症状评估和管理。
  • 制定激光治疗方案时应考虑年龄相关的生理差异,个体化安排治疗时间线。

局限性

  • 单中心回顾性设计可能限制结果外推。
  • 样本以非洲裔美国人和Fitzpatrick V型皮肤为主,其他肤色人群代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Evaluate the influence of patient age on laser therapy outcomes for burn hypertrophic scars (HTS), with a specific focus on assessing differences in scar quality, pain, and itch across stratified age groups. A single-institution, retrospective cohort study analyzing outcomes of fractional ablative CO2 laser treatments among patients grouped into younger, middle-aged, and older cohorts using k-means clustering. Patients (n = 119) receiving 3 or more fractional ablative CO2 laser treatments were included. Scar metrics were evaluated pretreatment and after each laser session using the Patient and Observer Scar Assessment Scale (POSAS), Vancouver Scar Scale, and durometer measurements. Statistical analyses were performed to compare within- and between-group outcomes using analysis of variance with corrections for multiple comparisons. The study cohort included 119 patients, with 49.58% female participants and an average age of 44.86 years (±16.4). The patients were predominantly African American (38.7%), followed by White (28.6%), Hispanic (10.9%), Asian (5.9%), Native American (1.7%), and 14.3% unspecified. Fitzpatrick skin type classifications were most common in types V (32.8%) and II (20.2%), with lower representation in types VI (4.2%) and I (1.7%). Laser treatment led to significant improvements across all age groups in POSAS metrics, though the timing and extent varied. The older cohort showed significant improvement in the POSAS observer pliability scale after just 1 session (P < .05), while the younger and middle-aged groups required 2 or more sessions (P < .001). Middle-aged patients reported the highest baseline pain and itch levels, with mean scores of 6.17/10 and 6.64/10, respectively, compared to younger (4.26 and 4.97) and older (4.26 and 4.74) groups (P < .05). Pain and itch significantly decreased across all groups, with the middle-aged cohort showing the most consistent improvements (P < .05). Vancouver Scar Scale scores improved significantly for all groups, while durometer measurements showed significant changes only in the middle-aged cohort (P < .05). Age significantly influences laser therapy outcomes for burn HTS, with older patients experiencing earlier and more pronounced improvements in POSAS observer scales. Different age groups also reported varying levels of pain and itch throughout their laser treatment sessions. Importantly, considerable improvements were noted postlaser treatment across all age groups. These findings emphasize the importance of personalizing laser therapy to address age-specific physiological changes to optimize treatment timelines and outcomes for patients with burn HTS.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Slavinsky V, Ching L, Carney BC, et al. Age as a Determinant: Investigating the Efficacy of Laser Treatment Outcomes for Burn Hypertrophic Scar Across Age Cohorts. J Burn Care Res. 2026. PMID: 42261654. doi:10.1093/jbcr/irag085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。